PIK3CA and breast cancer: Kishikawa et al. reported that WWP1’s regulation of PTEN reduces the effectiveness of PI3K inhibitors in BC treatment, while WWP1 inhibition restores PTEN function and suppresses the PI3K/AKT pathway (Kishikawa et al., 2021).